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Summary: 1. Human transferrin was labelled with Fe(III) in nitrilo triacetate buffer at one of its two metal binding
sites by variation of the pH. The -site was preferentially labelled at pH 7.2, the B-site at pH 9.2.
2. The monoferric transferrin preparations were subjected to preparative isoelectric focussing, isolated from the
granulated gels, and checked for homogeneity and purity on an analytical scale by isoelectric focussing.
3. The technique for obtaining stable monoferric transferrin (Fe)(A) and transferrin (Fe)(B) preparations is described
in detail.
Isolierung von Transferrin (Fe)(A) und Transferrin (Fe)(B) des Menschen durch präparative isoelektrische Fokussierung
Zusammenfassung: 1. Transferrin vom Menschen wurde mit Fe(III) in Nitrilotriacetatpuffer durch Variation des pH an
einer seiner zwei Metallbindungsstellen markiert. Bindungsstelle A wird Vorzugsweise bei pH 7,2, Bindungsstelle B bei
pH 9,2 markiert.
2. Die jeweils ein Eisen enthaltenden Transferrin-Präparationen wurden der präparativen isoelektrischen Fokussierung
unterworfen, aus dem granulierten Gel isoliert und durch analytische isoelektrische Fokussierung auf ihre Homogenität
und Reinheit geprüft.
3. Die Technik für die Darstellung stabiler, ein Eisen enthaltender Transferrine wird im Detail beschrieben.
Introduction
Transferrin is a ß-glpbulin responsible for carrying
iron in the plasma. This protein has a of 81000,
consists of a single polypeptide chain and has two metal
binding sites. There is still doubt whether the two
binding sites, called the B-site and -site, located in
the terminal domain, C terminal domain (1), respect-
ively fulfill different physiological roles (2,3). In a
previous paper we showed that these two binding sites
have different affinities for Fe(HI) at various pH values,
and that the isoelectric points of the two monoferric
transferrins differ by 0,1 pH unit (4). This was deter-
mined by the elegant flat bed isoelectric focussing
technique in polyaciylamide gel.
In this paper we present a preparative method, a flat-bed
isoelectrie focussing technique in granulated gels, which
enables us to separate and isolate each monoferric trans-
ferrins on a 10 mg level. By incubating individual trans-
ferrins with erythroid and parenchymal cells, it is possible
to investigate the question (suggested by Fletcher
ScHuehns over a decade ago) as to whether these two
binding sites of transferrin have distinctive roles in iron
transport and metabolism (5).
Materials and Methods
Human transferrin was obtained from Kabi (Sweden) and used
without further purification.
Apotransferrin was prepared as described earlier (6) by dialysis
against EDTA. A nitrilo triacetate (NTA) pH-buffer was made
by titration of Na3NTA with NTA (Sigma) until the desired pH
was obtained.
Chemicals were of analytical reagent grade.
AmpholinespH 5-7 and granulated gel (Ultrodex) were obtained
from LKB (Sweden). 5^Fe(III) citrate was obtained from Radio-
chemical Centre, Amersham, Bucks, United Kingdom and was
diluted about five fold with freshly prepared 56Fe(III) citrate
(0,6 g/1). To this solution NaHCO3 was added in a molar ratio
Fe/HC03= 1/50.
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Preparation of monoferric transferrins A and B
To a solution of human apotransferrin (ca. 60 g/1) 10 vol%
1 mol/1 NTA buffer was added of either pH = 7.2 (transferrin
(Fe)(A)) or 9.2 (transferrin(Fe)(B)).
Then the apotransferrin solutions were brought to a 0.60 Fe
saturation with the mixed 56Fe/59Fe citrate solution (about
1 mmol/1 Fe).
The Fe-transferrin solutions were kept overnight at room temper-
ature, then dialysed for 24 hours at 4 °C against 1 litre 0.1 mol/1
Tris pH = 7 (A), or pH = 9 (B). After dialysis the Fe-transferrin
solutions were used for preparative isoelectric focussing which
was carried out according to the Application Note 198 (LKB)
with the LKB 2117 Multiphor, but with a few minor adapta-
tions.
Instead of Sephadex G75, a new granulated gel, Ultrodex, was
used. Four (4) grams of the freeze dried powder was suspended
in 100 ml of a 20 g/l ampholine pH 5-7 solution. The focussing
was carried out over the broad-short region instead of the narrow
long region. Between the gel bearing glass plate and the cooling
glass plate two sheets of wetted filter paper were placed to make
it easier to distinguish the transferrin-Fe bands after focussing.
Before applying the sample, the gel was prerun for 60-90 minutes.
Instead of the low power and time-consuming adjustment given
by LKB, we started the prerun with 500 V and 50 mA, and these
values automatically changed during focussing to 900 V and
35 mA. Maxima of 1200 V, 30 W and 50 mA were adjusted. A
fast, high power focussing is necessary because the relative low
stability of transferrin(Fe)(B). Instead of mixing the sample
with the gel, it was absorbed into a dry electrode strip (ca.
70 μΐ/cm strip), then the strip was carefully pressed into the
gel parallel to the electrode strips at a distance of 1 cm from
the cathode.
The focussing was performed in 100-140 minutes until sharp
bands had been formed (visible from their pink color).
Next with a glass spatula the protein containing gel (zones) were
scooped into special elution columns (LKB, 2117-502). Trans-
ferrin(Fe)(A) and transferrin(Fe)(B) were eluted with 0.5 mol/1
Tris pH 7 or 8, respectively. The eluates were dialyzed over-
night at 4 °C against 11 each of a 0.02 mol/1 Tris buffer pH = 7
or 8, respectively. Elution and dialysis buffer were made Fe-free
by passing the solution through a small column of Chelex 100
(Biorad).
Finally the fractions were tested for homogeneity on a poly-
acrylamide gel on an analytical scale (4) and used for incubation
studies with rat reticulocy tes and bone marrow cells, as well as
with human bone marrow cells. These experiments are described
elsewhere (5).
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Fig. 1. Preparative isoelectric focussing.
Transferrin(Fej(A) (Fe N-terminal left) and transferrin-
(Fe)(B) (Fe C-terminal right) as well as transferrin(2Fe)
are visible.
of transferrin(Fe)(B) and some transferrin(2Fe) was
obtained in the focussing (left); if the sample was not
dialysed (i.e. the chelatprs were not removed) most of
the transferrin(Fe)(B) was converted to transferrin-
(Fe)(A) during the focussing (fig. 3 right). Surprisingly,
this conversion was not observed on the analytical gel
(fig. 1 right). The transferrin(Fe)(A) and transferrin-
(Fe)(B) preparations obtained from the preparative gels
were focussed again on an analytical scale. This result
is shown in figure 4.
Results
In figure 1 a typical diagram of the separation of speci-
fically labelled monoferric transferrin(Fe)(A) and trans-
ferrin(Fe)(B) is shown. On the left is a labelling at pH 7.2,
mainly Α-site, and in the middle a labelling at pH 9.2,
mainly the B-site. The labelling occurred in a NTA buffer,
the separation of 70 Mg samples on polyacrylamide gels
with isoelectric focussing as has been described earlier
(4). In figures 2 and 3 are shown the separation of about
7 mg samples in granulated gels (Ultrodex). The gels are
stained for iron, so apotransferrin is not visible. On the
left in figure 2 is shown transferrin(Fe)(A), and trans-
ferrin(Fe)(B) is on the right. In figure 3 is shown the
result of dialysing the sample after labelling the trans-
ferrin with Fe(III). If the sample of transferrin(Fe)(B)
was dialysed in order to remove chelators a sharp band
Discussion
With the method, described here in detail, it appears
possible to separate and isolate monoferric human
transferrins A and B. The yield is at least 20% under
favourable conditions.
We wish to draw attention on the conditions necessary
for optimal preparative focussing.
1. To obtain pure transferrin(Fe)(B) it is absolutely
necessary to remove NTA and citrate by dialysis or
gel filtration before transferrin(Fe)(B) solutions are
subjected to preparative focussing. If this step is
° omitted a considerable amount of transferrin(Fe)(B)
is converted into transferrin(Fe)(A) during focussing
and transferrin(Fe)(B) preparations are than con-
taminated with transferrin(Fe)(A).
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Fig. 2. The same solutions as in fig. 1, but on analytical gels.
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Fig. 3. Isoelectric focussing of (a) solutions which contain chelators, not removed before the focussing technique (left) and (b) solu-
tions from which chelators were removed before the focussing (right), in this case only transferrin(Fe)(B) is seen and not
transferrin(Fe)(A).
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Moreover the yield is diminished. Removing chelators
from transferrin(Fe)(A) solutions before focussing
resulted in sharper migration.
2. The optimal and most reproducible ratio of trans-
ferrin(Fe)(A) to transferrin(Fe)(B) was found when
the labelling of apotransferrin with Fe was carried out
in a NTA buffer, with an excess of HCO3~, so that
HC03" and not NTA is bound as an anion (7).
3. A solution of high concentration, at least 30 g/1, is
necessary in order to work with sample volumes of
1.5—2 ml and to obtain a reasonable amount of pro-
tein.
4. To prove that the ampholine had no harmful effect
on the nature of the protein we carried out several
incubation experiments with reticulocytes and trans-
ferrin-solutions, treated or non-treated with ampho-
line. No differences were observed in iron uptake (5).
Fig. 4. Isoelectric focussing on an analytical scale of samples
prepared by the preparative technique.
The pure transferrin(Fe)(A)(left) and t_ransferrin(Fe)(B)-
(right) obtained by preparative isoelectric focussing,
dialysed as described and ready for incubation experi-
ment.
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